Influenza and Other Respiratory Viruses

Papers
(The TQCC of Influenza and Other Respiratory Viruses is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
COVID‐19 vaccine hesitancy and attitudes in Qatar: A national cross‐sectional survey of a migrant‐majority population113
Increased risk of rhinovirus infection in children during the coronavirus disease‐19 pandemic98
Respiratory syncytial virus disease burden in adults aged 60 years and older in high‐income countries: A systematic literature review and meta‐analysis84
Influenza and COVID‐19: What does co‐existence mean?77
SARS‐CoV‐2 environmental contamination associated with persistently infected COVID‐19 patients60
COVID‐19 severity from Omicron and Delta SARS‐CoV‐2 variants60
Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis56
Differential COVID‐19 case positivity in New York City neighborhoods: Socioeconomic factors and mobility52
Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID‐19) from Zhejiang province in China51
Which influenza viruses will emerge following the SARS‐CoV‐2 pandemic?48
Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID‐19 pandemic48
Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries48
Evidence for pre‐symptomatic transmission of coronavirus disease 2019 (COVID‐19) in China47
The economic burden of influenza among adults aged 18 to 64: A systematic literature review40
Admission respiratory status predicts mortality in COVID‐1939
International changes in respiratory syncytial virus (RSV) epidemiology during the COVID‐19 pandemic: Association with school closures37
The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review34
Population anxiety and positive behaviour change during the COVID‐19 epidemic: Cross‐sectional surveys in Singapore, China and Italy33
The impact of the 2009 influenza pandemic on the seasonality of human respiratory syncytial virus: A systematic analysis33
Associations between persistent symptoms after mild COVID‐19 and long‐term health status, quality of life, and psychological distress31
Severity and mortality of respiratory syncytial virus vs influenza A infection in hospitalized adults in China26
Impact of coronavirus disease 2019 on respiratory surveillance and explanation of high detection rate of human rhinovirus during the pandemic in the Republic of Korea25
Healthcare workers in Singapore infected with COVID‐19: 23 January‐17 April 202023
Using the health belief model to identify barriers to seasonal influenza vaccination among Australian adults in 201923
Transmission of SARS‐CoV‐2 during a 2‐h domestic flight to Okinawa, Japan, March 202023
Re‐emergence of influenza virus circulation during 2020 in parts of tropical Asia: Implications for other countries22
Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017–201922
Adenovirus infection in children hospitalized with pneumonia in Guangzhou, China22
Estimating the burden of adult hospital admissions due to RSV and other respiratory pathogens in England21
Household transmission of COVID‐19 among the earliest cases in Antananarivo, Madagascar20
Absence of association between 2019‐20 influenza vaccination and COVID‐19: Results of the European I‐MOVE‐COVID‐19 primary care project, March‐August 202020
Impact of varying wave periods of COVID‐19 on in‐hospital mortality and length of stay for admission through emergency department: A territory‐wide observational cohort study20
The burden of seasonal influenza in Italy: A systematic review of influenza‐related complications, hospitalizations, and mortality19
The COVID‐19 epidemic in Madagascar: clinical description and laboratory results of the first wave, march‐september 202019
The role of non‐pharmaceutical interventions on influenza circulation during the COVID‐19 pandemic in nine tropical Asian countries19
Epidemiological and clinical features of SARS‐CoV‐2 infection in children during the outbreak of Omicron variant in Shanghai, March 7–31, 202218
Population‐based assessment of risks for severe COVID‐19 disease outcomes18
Comprehensive assessment of amino acid substitutions in the trimeric RNA polymerase complex of influenza A virus detected in clinical trials of baloxavir marboxil18
Factors associated with COVID‐19 related hospitalisation, critical care admission and mortality using linked primary and secondary care data17
Symptoms and recovery among adult outpatients with and without COVID‐19 at 11 healthcare facilities—July 2020, United States17
Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults17
Antibody responses to COVID‐19 vaccination in people with obesity: A systematic review and meta‐analysis16
Asymptomatic transmission of SARS‐CoV‐2 and implications for mass gatherings16
Clinical manifestations of COVID‐19 differ by age and obesity status16
Pre‐symptomatic transmission of novel coronavirus in community settings16
Epidemiology and burden of illness of seasonal influenza among the elderly in Japan: A systematic literature review and vaccine effectiveness meta‐analysis16
Risk factors for outbreaks of COVID‐19 in care homes following hospital discharge: A national cohort analysis16
Epidemiology of respiratory viruses in patients with severe acute respiratory infections and influenza‐like illness in Suriname16
Epidemiological and clinical characteristics of respiratory syncytial virus and influenza infections in hospitalized children before and during the COVID‐19 pandemic in Central China15
ROSES‐S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS‐CoV‐215
Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post‐discharge assessed by Respiratory Intensity a15
Global patterns of seasonal influenza activity, duration of activity and virus (sub)type circulation from 2010 to 202015
Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness15
Differentiating impacts of non‐pharmaceutical interventions on non‐coronavirus disease‐2019 respiratory viral infections: Hospital‐based retrospective observational study in Taiwan15
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study15
Diagnostic performance of COVID‐19 serological assays during early infection: A systematic review and meta‐analysis of 11 516 samples14
Severe acute respiratory syndrome coronavirus 2 can be detected in exhaled aerosol sampled during a few minutes of breathing or coughing14
A six‐plex droplet digital RT‐PCR assay for seasonal influenza virus typing, subtyping, and lineage determination14
A Sanger sequencing protocol for SARS‐CoV‐2 S‐gene14
Cohort profile: A Prospective Household cohort study of Influenza, Respiratory syncytial virus and other respiratory pathogens community burden and Transmission dynamics in South Africa, 2016–201814
Viral epidemiology and SARS‐CoV‐2 co‐infections with other respiratory viruses during the first COVID‐19 wave in Paris, France14
Determination of respiratory syncytial virus epidemic seasons by using 95% confidence interval of positivity rates, 2011–2021, Germany14
Novel and extendable genotyping system for human respiratory syncytial virus based on whole‐genome sequence analysis14
Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in MIRACLE clinical trial13
Predictors of all‐cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS‐CoV‐213
Seasonal influenza in children: Costs for the health system and society in Europe13
Delayed respiratory syncytial virus outbreak in 2020 in Taiwan was correlated with two novel RSV‐A genotype ON1 variants13
Risk of symptomatic COVID‐19 due to aircraft transmission: a retrospective cohort study of contact‐traced flights during England’s containment phase13
Characterization of community‐wide transmission of SARS‐CoV‐2 in congregate living settings and local public health‐coordinated response during the initial phase of the COVID‐19 pandemic13
Burden and severity of children's hospitalizations by respiratory syncytial virus in Portugal, 2015–201813
Clinical characteristics and population‐based attack rates of respiratory syncytial virus versus influenza hospitalizations among adults—An observational study13
Home collection of nasal swabs for detection of influenza in the Household Influenza Vaccine Evaluation Study13
Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study13
Epidemiological analysis of the first 1000 cases of SARS‐CoV‐2 lineage BA.1 (B.1.1.529, Omicron) compared with co‐circulating Delta in Wales, UK12
Etiologies of severe acute respiratory infection (SARI) and misdiagnosis of influenza in Indonesia, 2013‐201612
Respiratory syncytial virus seasonality in three epidemiological zones of Kenya12
Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision‐making and communication12
Record high parainfluenza season in children after relaxation of COVID‐19 restrictions in fall 2021—A nationwide register study in Finland12
Incidence of influenza virus infections confirmed by serology in children and adult in a suburb community, northern China, 2018‐2019 influenza season12
Oseltamivir treatment of influenza A and B infections in infants12
Upsurge of human rhinovirus infection followed by a delayed seasonal respiratory syncytial virus infection in Thai children during the coronavirus pandemic12
Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand12
Population‐based hospitalization burden estimates for respiratory viruses, 2015–201911
Interactions among common non‐SARS‐CoV‐2 respiratory viruses and influence of the COVID‐19 pandemic on their circulation in New York City11
National seroepidemiological study of COVID‐19 after the initial rollout of vaccines: Before and at the peak of the Omicron‐dominant period in Japan11
COVID‐19 outbreaks in aged‐care facilities in Australia11
The REinfection in COVID‐19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers11
Systematic literature review of the signs and symptoms of respiratory syncytial virus11
Household transmission of SARS‐CoV‐2 during the Omicron wave in Shanghai, China: A case‐ascertained study11
Determining the seasonality of respiratory syncytial virus in Slovenia11
Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 202211
Epidemiology of acute lower respiratory tract infection hospitalizations in Thai children: A 5‐year national data analysis11
Respiratory syncytial virus in pediatric influenza‐like illness cases in Lombardy, Northern Italy, during seven consecutive winter seasons (from 2014–2015 to 2020–2021)10
Estimating the burden of influenza‐related and associated hospitalizations and deaths in France: An eight‐season data study, 2010–201810
Changes in virus detection in hospitalized children before and after the severe acute respiratory syndrome coronavirus 2 pandemic10
Impact of respiratory syncytial virus disease on quality of life in adults aged ≥50 years: A qualitative patient experience cross‐sectional study10
Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic10
Age‐related risk of household transmission of COVID‐19 in Singapore10
The importance of influenza vaccination during the COVID‐19 pandemic10
Health‐seeking behaviors of patients with acute respiratory infections during the outbreak of novel coronavirus disease 2019 in Wuhan, China10
Intravenous peramivir vs oral oseltamivir in high‐risk emergency department patients with influenza: Results from a pilot randomized controlled study10
Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID‐19 cases treated with sotrovimab in the community in England10
Respiratory viral coinfection in a birth cohort of infants in rural Nepal10
All‐cause versus cause‐specific excess deaths for estimating influenza‐associated mortality in Denmark, Spain, and the United States10
Comparative incidence and burden of respiratory viruses associated with hospitalization in adults in New York City10
Human respiratory syncytial virus diversity and epidemiology among patients hospitalized with severe respiratory illness in South Africa, 2012–201510
Independent association between meteorological factors, PM2.5, and seasonal influenza activity in Hangzhou, Zhejiang province, China9
Epidemiology of SARS‐CoV‐2 infection and SARS‐CoV‐2 positive hospital admissions among children in South Africa9
Prevalence and seasonality of viral respiratory infections in a temperate climate region: A 24‐year study (1997–2020)9
One benefit of COVID‐19 measures in Taiwan: The reduction of influenza infections and severe complications9
Respiratory viruses in pediatric emergency department patients and their family members9
Some characteristics of clinical sequelae of COVID‐19 survivors from Wuhan, China: A multi‐center longitudinal study9
Public health and social measures during health emergencies such as the COVID‐19 pandemic: An initial framework to conceptualize and classify measures9
Factors associated with early uptake of COVID‐19 vaccination among healthcare workers in Azerbaijan, 20219
No evidence for HPAI H5N1 2.3.4.4b incursion into Australia in 20229
Live SARS‐CoV‐2 is difficult to detect in patient aerosols8
Impact of respiratory viral infections on mortality and critical illness among hospitalized patients with chronic obstructive pulmonary disease8
Predictors of influenza severity among hospitalized adults with laboratory confirmed influenza: Analysis of nine influenza seasons from the Valencia region, Spain8
A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom8
Occurrence and disease burden of respiratory syncytial virus and other respiratory pathogens in adults aged ≥65 years in community: A prospective cohort study in Japan8
Epidemiological and clinical characteristics of community‐acquired and nosocomial influenza cases and risk factors associated with complications: A four season analysis of all adult patients admitted 8
Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 20228
Relative timing of respiratory syncytial virus epidemics in summer 2021 across the United States was similar to a typical winter season8
The effect of nirmatrelvir‐ritonavir on viral clearance and length of hospital stay in patients infected with SARS‐CoV‐2 omicron variants8
Zanamivir aqueous solution in severe influenza: A global Compassionate Use Program, 2009–20198
Role of age and birth month in infants hospitalized with RSV‐confirmed disease in the Valencia Region, Spain8
mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 20218
Molecular epidemiology of Enteroviruses and Rhinoviruses in patients with acute respiratory infections in Yaounde, Cameroon8
Modelling the influenza disease burden in people aged 50–64 and ≥65 years in Australia8
Consistency of self‐reported and documented historical influenza vaccination status of US healthcare workers7
Acute respiratory infection emergency access in a tertiary care children hospital in Italy, prior and after the SARS‐CoV‐2 emergence7
Respiratory syncytial virus‐associated acute respiratory illness in adult non‐immunocompromised patients: Outcomes, determinants of outcomes, and the effect of oral ribavirin treatment7
Epidemiology and outcome of influenza‐associated infections among hospitalized patients with acute respiratory infections, Egypt national surveillance system, 2016‐20197
Horses for courses? Assessing the potential value of a surrogate, point‐of‐care test for SARS‐CoV‐2 epidemic control7
Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 20227
Cumulative incidence of post‐infection asthma or wheezing among young children clinically diagnosed with respiratory syncytial virus infection in the United States: A retrospective database analysis7
Epidemiological trends in notified influenza cases in Australia’s Northern Territory, 2007‐20167
Implications of the unexpected persistence of human rhinovirus/enterovirus during the COVID‐19 pandemic in Canada7
Clinical significance of SARS‐CoV‐2‐specific IgG detection with a rapid antibody kit for COVID‐19 patients7
The Oregon Child Absenteeism Due to Respiratory Disease Study (ORCHARDS): Rationale, objectives, and design7
The national burden of influenza‐like illness and severe respiratory illness overall and associated with nine respiratory viruses in South Africa, 2013–20157
Using serological measures to estimate influenza incidence in the presence of secular trends in exposure and immuno‐modulation of antibody response7
Bacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 20227
0.025928020477295